RIGEL PHARMACEUTICALS, INC. Severance Costs
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Severance Costs of $1.10 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2016-05-03
- RIGEL PHARMACEUTICALS, INC. severance costs for fiscal 2015 was $1.10M, a 0.00% change from fiscal 2014.
- RIGEL PHARMACEUTICALS, INC. severance costs for fiscal 2014 was $1.10M.
| Period end | Severance Costs | Severance Costs 12 month |
|---|---|---|
| 2015-12-31 | $1.10M 10-K · filed 2016-03-08 | |
| 2015-01-01 | $1.10M 10-Q · filed 2016-05-03 | |
| 2014-12-31 | $1.10M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |